This article is more than 5 years old. Information may no longer be current.

TearLab reports 28% increase in revenue in first quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

TearLab reported net revenue of $5.4 million in the first quarter 2015, a 28% increase from $4.2 million in the first quarter of the previous year, according to a press release.

Net loss was reported at $8.2 million, or $0.24 per share on a non-diluted basis, in the first quarter, compared with $5.6 million, or $0.17 per share on a non-diluted basis, in the first quarter a year ago.

General and administrative expenses were reported at $3.6 million in the first quarter compared with $3.1 million in the first quarter 2014. Clinical, regulatory, and research and development expenses were reported at $1.4 million compared with $575,000 in the first quarter of the previous year.